Page last updated: 2024-10-22

amlodipine and Hepatocellular Carcinoma

amlodipine has been researched along with Hepatocellular Carcinoma in 1 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Shiozaki, A1
Kurashima, K1
Kudou, M1
Shimizu, H1
Kosuga, T1
Takemoto, K1
Arita, T1
Konishi, H1
Yamamoto, Y1
Morimura, R1
Komatsu, S1
Ikoma, H1
Kubota, T1
Fujiwara, H1
Otsuji, E1

Other Studies

1 other study available for amlodipine and Hepatocellular Carcinoma

ArticleYear
Cancer Stem Cells of Hepatocellular Carcinoma Are Suppressed by the Voltage-gated Calcium Channel Inhibitor Amlodipine.
    Anticancer research, 2023, Volume: 43, Issue:11

    Topics: Amlodipine; Calcium Channels; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Neoplastic Stem Ce

2023